TY - JOUR AU - Uwe, Zeymer AU - Peter, Ludman AU - Nicolas, Danchin AU - Petr, Kala AU - Aldo P., Maggioni AU - Franz, Weidinger ED - Kiss, RG / Collaborator ED - Becker, D / Collaborator ED - Nowotta, F / Collaborator ED - Tóth, K / Collaborator ED - Szabó, S / Collaborator ED - Lakatos, C / Collaborator ED - Jambrik, Zoltán / Collaborator ED - Ruzsa, J / Collaborator ED - Ruzsa, Zoltán / Collaborator ED - Róna, S / Collaborator ED - Toth, J / Collaborator ED - Vargane Kosik, A / Collaborator ED - Toth, KSB / Collaborator ED - Nagy, Gergely György / Collaborator ED - Ondrejkó, Z / Collaborator ED - Körömi, Z / Collaborator ED - Botos, B / Collaborator TI - The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry JF - EUROPEAN HEART JOURNAL - QUALITY OF CARE AND CLINICAL OUTCOMES J2 - EHJ-QCCO VL - 6 PY - 2020 IS - 2 SP - 100 EP - 104 PG - 5 SN - 2058-5225 DO - 10.1093/ehjqcco/qcz042 UR - https://m2.mtmt.hu/api/publication/31674910 ID - 31674910 N1 - Members are listed in the Supplementary material online, Appendix 1. https://academic.oup.com/ehjqcco/article/6/2/100/5540332#supplementary-data AB - Aims The Acute Cardiac Care Association (ACCA)-European Association of Percutaneous Coronary Intervention (EAPCI) Registry on ST-elevation myocardial infarction (STEMI) of the EurObservational programme (EORP) of the European Society of Cardiology (ESC) registry aimed to determine the current state of the use of reperfusion therapy in ESC member and ESC affiliated countries and the adherence to ESC STEMI guidelines in patients with STEMI. Methods and results Between 1 January 2015 and 31 March 2018, a total of 11 462 patients admitted with an initial diagnosis of STEMI according to the 2012 ESC STEMI guidelines were enrolled. Individual patient data were collected across 196 centres and 29 countries. Among the centres, there were 136 percutaneous coronary intervention centres and 91 with cardiac surgery on-site. The majority of centres (129/196) were part of a STEMI network. The main objective of this study was to describe the demographic, clinical, and angiographic characteristics of patients with STEMI. Other objectives include to assess management patterns and in particular the current use of reperfusion therapies and to evaluate how recommendations of most recent STEMI European guidelines regarding reperfusion therapies and adjunctive pharmacological and non-pharmacological treatments are adopted in clinical practice and how their application can impact on patients' outcomes. Patients will be followed for 1 year after admission. Conclusion The ESC ACCA-EAPCI EORP ACS STEMI registry is an international registry of care and outcomes of patients hospitalized with STEMI. It will provide insights into the contemporary patient profile, management patterns, and 1-year outcome of patients with STEMI. LA - English DB - MTMT ER - TY - JOUR AU - Jánosi, András AU - Ofner, P AU - Forster, Tamás AU - Édes, I AU - Tóth, Kálmán AU - Merkely, Béla Péter TI - Clinical characteristics, hospital care, and prognosis of patients with ST elevation myocardial infarction: Hungarian Myocardial Infarction Registry JF - EUROPEAN HEART JOURNAL SUPPLEMENTS J2 - EUR HEART J SUPPL VL - 16 PY - 2014 IS - Suppl. A SP - A12 EP - A15 SN - 1520-765X DO - 10.1093/eurheartj/sut004 UR - https://m2.mtmt.hu/api/publication/2541114 ID - 2541114 LA - English DB - MTMT ER - TY - JOUR AU - Kristensen, SD AU - Laut, KG AU - Fajadet, J AU - Kaifoszova, Z AU - Kala, P AU - Di Mario, C AU - Wijns, W AU - Clemmensen, P AU - Agladze, V AU - Antoniades, L AU - Alhabib, KF AU - De Boer, MJ AU - Claeys, MJ AU - Deleanu, D AU - Dudek, D AU - Erglis, A AU - Gilard, M AU - Goktekin, O AU - Guagliumi, G AU - Gudnason, T AU - Hansen, KW AU - Huber, K AU - Janota, T AU - Jennings, S AU - Kajander, O AU - Kanakakis, J AU - Karamfiloff, KK AU - Kedev, S AU - Kornowski, R AU - Ludman, PF AU - Merkely, Béla Péter AU - Milicic, D AU - Najafov, R AU - Nicolini, FA AU - Noc, M AU - Ostojic, M AU - Pereira, H AU - Radovanovic, D AU - Sabate, M AU - Sobhy, M AU - Sokolov, M AU - Studencan, M AU - Terzic, I AU - Wahler, S AU - Widimsky, P AU - On, behalf of the European Association for Percutaneous Cardiovascular Interventions ED - Mühlberger, V / Collaborator ED - Najafov, R / Collaborator ED - Legrand, V / Collaborator ED - Spuzic, M / Collaborator ED - Hajric, R / Collaborator ED - Markota, D / Collaborator ED - Srdic, S / Collaborator ED - Jorgova, J / Collaborator ED - Velchev, V / Collaborator ED - Petrov, I / Collaborator ED - Nikolic, Heitzler V / Collaborator ED - Babic, Z / Collaborator ED - Nicolaides, E / Collaborator ED - Christodulides, T / Collaborator ED - Georgiou, P / Collaborator ED - Jansky, P / Collaborator ED - Stasek, J / Collaborator ED - Terkelsen, CJ / Collaborator ED - Galatius, S / Collaborator ED - Sørensen, R / Collaborator ED - Sobhy, M / Collaborator ED - El, Shal A / Collaborator ED - Romppanen, H / Collaborator ED - Müller, A / Collaborator ED - Rustige, J / Collaborator ED - Alexopoulos, D / Collaborator ED - Kallikazaros, I / Collaborator ED - Papaioannou, G / Collaborator ED - Becker, Dávid / Collaborator ED - Ungi, Imre / Collaborator ED - Kiss, Róbert Gábor / Collaborator ED - Skuladottir, FB / Collaborator ED - Bjornsdottir, TK / Collaborator ED - Cavanagh, B / Collaborator ED - Twomey, K / Collaborator ED - Daly, K / Collaborator ED - Matetzky, S / Collaborator ED - De Luca, L / Collaborator ED - Cremonesi, A / Collaborator ED - Bovenzi, F / Collaborator ED - Zakke, I / Collaborator ED - Maca, A / Collaborator ED - Narbute, I / Collaborator ED - Antov, S / Collaborator ED - Koch, KT / Collaborator ED - Mimoso, J / Collaborator ED - Almeida, M / Collaborator ED - Pereira, E / Collaborator ED - Tatu, G / Collaborator ED - Vinereanu, D / Collaborator ED - D'Angeli, C / Collaborator ED - Nedeljkovic, M / Collaborator ED - Vukcevic, V / Collaborator ED - Dobric, M / Collaborator ED - Hricak, V / Collaborator ED - Kovař, F / Collaborator ED - Kurray, P / Collaborator ED - Peral, V / Collaborator ED - Tresserras, R / Collaborator ED - Regueiro, A / Collaborator ED - Erne, P / Collaborator ED - Rickli, H / Collaborator ED - Windecker, S / Collaborator ED - Kozan, O / Collaborator ED - Ertas, G / Collaborator ED - Kervan, U / Collaborator ED - Birkhead, J / Collaborator ED - Sokolov, Y / Collaborator TI - Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries JF - EUROPEAN HEART JOURNAL J2 - EUR HEART J VL - 35 PY - 2014 IS - 29 SP - 1957 EP - 1970 PG - 14 SN - 0195-668X DO - 10.1093/eurheartj/eht529 UR - https://m2.mtmt.hu/api/publication/2540750 ID - 2540750 N1 - Erratum in: Eur Heart J. 2014 Oct 7;35(38):2697. AB - AIMS: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. METHODS AND RESULTS: A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. CONCLUSION: Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged. LA - English DB - MTMT ER -